Download PDF
Am J Perinatol
DOI: 10.1055/a-2278-9279
SMFM Fellows Research Series

The Cost of Developing and Implementing an Antepartum Referral Program for Penicillin Allergy Evaluation at a Single Academic Tertiary Care Hospital

Martina S. Burn
1   Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
2   Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota
,
Xiao Xu
1   Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
,
Jason Kwah
3   Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
,
Jane Liao
3   Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
,
Moeun Son
1   Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objective Approximately 10% of pregnant individuals report a penicillin allergy, yet most are not truly allergic. Allergy verification during pregnancy is safe and recommended; however, many hospitals lack the infrastructure to execute testing. Our aim was to evaluate the cost of developing and implementing a penicillin allergy referral program for pregnant individuals at an academic institution and to compare costs of care between patients who were referred and not referred through the program.

Study Design We conducted an economic analysis of our institution's antepartum penicillin allergy referral program. We prospectively collected detailed resource utilization data and conducted the analysis from the program's perspective, accounting for costs related to program development, allergy verification, antibiotic cost, and delivery hospitalization. Costs were compared between patients who were referred for evaluation versus patients who were not referred using bivariate tests as well as quantile regression adjusting for baseline differences. A sensitivity analysis was performed for allergy testing cost. All cost estimates were inflation adjusted to 2021 U.S. dollars.

Results The startup cost of program development and educational initiatives was $19,920, or $86 per patient. The median allergy evaluation cost was $397 (interquartile range: $303–$663). There was no significant difference in maternal (median: $13,579 vs. $13,999, p = 0.94) or neonatal (median: $3,565 vs. $3,577, p = 0.55) delivery hospitalization cost or antibiotic cost (median: $1.57 vs. $3.87, p = 0.10) between referred and nonreferred patients. Overall, the total cost per person did not differ significantly between study groups (median: $18,931 vs. $18,314, p = 0.69).

Conclusion The cost of developing a penicillin allergy referral program in pregnancy was modest and did not significantly alter short-term cost of care with potential for long-term cost benefit. Verification of a reported penicillin allergy is an integral part of antibiotic stewardship, and the pregnancy period should be utilized as an important opportunity to perform this evaluation.

Key Points

  • The cost of developing and implementing an antepartum penicillin allergy referral program is modest.

  • Program cost did not significantly alter short-term cost with a potential for long-term cost benefit.

  • Penicillin allergy verification is an important part of antibiotic stewardship and should be expanded.

Keywords

allergy in pregnancy - penicillin allergy - β-lactam allergy - allergy - cost - referral program

Note

This study was orally presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine, San Francisco, California, February 6 − February 11, 2023.




Publication History

Received: 30 November 2023

Accepted: 26 February 2024

Accepted Manuscript online:
29 February 2024

Article published online:
21 March 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA 2019; 321 (02) 188-199
    CrossrefPubMedGoogle Scholar
  • 2 Macy E. Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep 2014; 14 (11) 476
    CrossrefPubMedGoogle Scholar
  • 3 Palmsten K, Hernández-Díaz S, Chambers CD. et al. The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid program. Obstet Gynecol 2015; 126 (03) 465-473
    CrossrefPubMedGoogle Scholar
  • 4 Kwah JH, Burn MS, Liao J, Cate J, Son M. Outpatient penicillin allergy evaluation during pregnancy and associated clinical outcomes. Am J Obstet Gynecol MFM 2022; 4 (05) 100674
    CrossrefPubMedGoogle Scholar
  • 5 Blanca M, Torres MJ, García JJ. et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999; 103 (5 Pt 1): 918-924
    CrossrefPubMedGoogle Scholar
  • 6 Sacco KA, Bates A, Brigham TJ, Imam JS, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis. Allergy 2017; 72 (09) 1288-1296
    CrossrefPubMedGoogle Scholar
  • 7 Gadde J, Spence M, Wheeler B, Adkinson Jr NF. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270 (20) 2456-2463
    CrossrefPubMedGoogle Scholar
  • 8 Macy E, Blumenthal KG. Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?. J Allergy Clin Immunol Pract 2018; 6 (01) 82-89
    CrossrefPubMedGoogle Scholar
  • 9 Picard M, Robitaille G, Karam F. et al. Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses. J Allergy Clin Immunol Pract 2019; 7 (08) 2722-2738.e5
    CrossrefPubMedGoogle Scholar
  • 10 Cate JJM, Burn M, Kwah J. et al. Survey of obstetric providers to assess the knowledge and management of a reported penicillin allergy in pregnant women. Am J Perinatol 2023; 40 (01) 1-8
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Desai SH, Kaplan MS, Chen Q, Macy EM. Morbidity in pregnant women associated with unverified penicillin allergies, antibiotic use, and group B streptococcus infections. Perm J 2017; 21: 16-80
    CrossrefPubMedGoogle Scholar
  • 12 Hopkins MK, Dotters-Katz S, Boggess K, Heine RP, Smid M. Perioperative antibiotic choice in labored versus unlabored cesareans and risk of postcesarean infectious morbidity. Am J Perinatol 2018; 35 (02) 127-133
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Nanduri SA, Petit S, Smelser C. et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr 2019; 173 (03) 224-233
    CrossrefPubMedGoogle Scholar
  • 14 Azmy V, Lundsberg LS, Culhane J, Kwah J, Partridge C, Son M. Pregnant Patients with a Documented History of Penicillin Allergy and Associated Maternal and Neonatal Outcomes at a Tertiary Care Center. Am J Perinatol 2023; DOI: 10.1055/a-2096-5002. . Epub ahead of print.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Jeffres MN, Narayanan PP, Shuster JE, Schramm GE. Consequences of avoiding β-lactams in patients with β-lactam allergies. J Allergy Clin Immunol 2016; 137 (04) 1148-1153
    CrossrefPubMedGoogle Scholar
  • 16 Li M, Krishna MT, Razaq S, Pillay D. A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of 'penicillin allergy' in a UK teaching hospital. J Clin Pathol 2014; 67 (12) 1088-1092
    CrossrefPubMedGoogle Scholar
  • 17 MacFadden DR, LaDelfa A, Leen J. et al. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study. Clin Infect Dis 2016; 63 (07) 904-910
    CrossrefPubMedGoogle Scholar
  • 18 Sade K, Holtzer I, Levo Y, Kivity S. The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 2003; 33 (04) 501-506
    CrossrefPubMedGoogle Scholar
  • 19 Prevention of Group B Streptococcal Early-Onset Disease in Newborns. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee opinion summary, number 782. Obstet Gynecol 2019; 134 (01) 1
    PubMedGoogle Scholar
  • 20 Penicillin Allergy in Antibiotic Resistance Workgroup. Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. J Allergy Clin Immunol Pract 2017; 5 (02) 333-334
    CrossrefPubMedGoogle Scholar
  • 21 Khan DA, Banerji A, Blumenthal KG. et al; Chief Editor(s), Workgroup Contributors, Joint Task Force on Practice Parameters Reviewers. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol 2022; 150 (06) 1333-1393
    CrossrefPubMedGoogle Scholar
  • 22 Macy E. Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 2006; 97 (02) 164-168
    CrossrefPubMedGoogle Scholar
  • 23 Kuder MM, Lennox MG, Li M, Lang DM, Pien L. Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy. Ann Allergy Asthma Immunol 2020; 125 (06) 646-651
    CrossrefPubMedGoogle Scholar
  • 24 Desravines N, Waldron J, Venkatesh KK, Kwan M, Boggess KA. Outpatient penicillin allergy testing in pregnant women who report an allergy. Obstet Gynecol 2021; 137 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 25 Wolfson AR, Mancini CM, Banerji A. et al. Penicillin allergy assessment in pregnancy: safety and impact on antibiotic use. J Allergy Clin Immunol Pract 2021; 9 (03) 1338-1346
    CrossrefPubMedGoogle Scholar
  • 26 Philipson EH, Lang DM, Gordon SJ, Burlingame JM, Emery SP, Arroliga ME. Management of group B streptococcus in pregnant women with penicillin allergy. J Reprod Med 2007; 52 (06) 480-484
    PubMedGoogle Scholar
  • 27 Thao V, Sharpe EE, Dholakia R. et al. Evaluating the cost-effectiveness of testing pregnant women for penicillin allergy. PLoS One 2023; 18 (01) e0280151
    CrossrefPubMedGoogle Scholar
  • 28 U.S Bureau of Labor Statistics: Occupational Employment and Wage Statistics. 2020. Accessed 12 March, 2024 at: https://www.bls.gov/oes/2020/may/oes_nat.htm#00-0000
    PubMed
  • 29 2018 Survey of America's Physicians Practice Patterns & Perspectives. 2018. Accessed 12 March, 2024 at: https://physiciansfoundation.org/wp-content/uploads/2018/09/physicians-survey-results-final-2018.pdf
    PubMed
  • 30 2020 Results of the AAMC Survey of Resident/Fellow Stipends and Benefits. 2020. Accessed 12 March, 2024 at: https://www.aamc.org/data-reports/students-residents/report/aamc-survey-resident/fellow-stipends-and-benefits
    PubMed
  • 31 2020 Centers for Medicare & Medicaid Services Physician Fee Schedule Look-Up Tool. 2020. Accessed 12 March, 2024 at: https://www.cms.gov/medicare/physician-fee-schedule/search/overview
    PubMed
  • 32 Blumenthal KG, Li Y, Banerji A, Yun BJ, Long AA, Walensky RP. The cost of penicillin allergy evaluation. J Allergy Clin Immunol Pract 2018; 6 (03) 1019-1027.e2
    CrossrefPubMedGoogle Scholar
  • 33 Peterson C, Xu L, Florence C, Grosse SD, Annest JL. Professional fee ratios for US hospital discharge data. Med Care 2015; 53 (10) 840-849
    CrossrefPubMedGoogle Scholar
  • 34 2020 Centers for Medicare & Medicaid Services Medicare Part B Drug and Biological Average Sales Price Quarterly Payment Files. 2020. Accessed 12 March, 2024 at: https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/2020-asp-drug-pricing-files
    PubMed
  • 35 U.S. Bureau of Labor Statistics. Consumer Price Index (CPI) Databases. Washington, DC. 2023. Accessed 12 March, 2024 at: https://www.bls.gov/cpi/data.htm
    PubMed
  • 36 Husereau D, Drummond M, Augustovski F. et al; CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Eur J Health Econ 2022; 23 (08) 1309-1317
    CrossrefPubMedGoogle Scholar
  • 37 Macy E, Vyles D. Who needs penicillin allergy testing?. Ann Allergy Asthma Immunol 2018; 121 (05) 523-529
    CrossrefPubMedGoogle Scholar
  • 38 Mak R, Yuan Zhang B, Paquette V. et al. Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital. J Allergy Clin Immunol Pract 2022; 10 (07) 1919-1921.e1
    CrossrefPubMedGoogle Scholar
  • 39 Iammatteo M, Alvarez Arango S, Ferastraoaru D. et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract 2019; 7 (01) 236-243
    CrossrefPubMedGoogle Scholar
  • 40 Cooper L, Harbour J, Sneddon J, Seaton RA. Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge: a systematic review. JAC Antimicrob Resist 2021; 3 (01) dlaa123
    CrossrefPubMedGoogle Scholar
  • 41 Kuruvilla M, Shih J, Patel K, Scanlon N. Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy. Allergy Asthma Proc 2019; 40 (01) 57-61
    CrossrefPubMedGoogle Scholar
  • 42 Mattingly II TJ, Fulton A, Lumish RA. et al. The cost of self-reported penicillin allergy: a systematic review. J Allergy Clin Immunol Pract 2018; 6 (05) 1649-1654.e4
    CrossrefPubMedGoogle Scholar
  • 43 Sousa-Pinto B, Blumenthal KG, Macy E. et al. Penicillin allergy testing is cost-saving: an economic evaluation study. Clin Infect Dis 2021; 72 (06) 924-938
    CrossrefPubMedGoogle Scholar
  • 44 Chen JR, Tarver SA, Alvarez KS, Wei W, Khan DA. Improving aztreonam stewardship and cost through a penicillin allergy testing clinical guideline. Open Forum Infect Dis 2018; 5 (06) ofy106
    CrossrefPubMedGoogle Scholar
  • 45 Jones BM, Bland CM. Penicillin skin testing as an antimicrobial stewardship initiative. Am J Health Syst Pharm 2017; 74 (04) 232-237
    CrossrefPubMedGoogle Scholar
  • 46 King EA, Challa S, Curtin P, Bielory L. Penicillin skin testing in hospitalized patients with β-lactam allergies: effect on antibiotic selection and cost. Ann Allergy Asthma Immunol 2016; 117 (01) 67-71
    CrossrefPubMedGoogle Scholar
  • 47 Vyles D, Chiu A, Routes J. et al. Antibiotic use after removal of penicillin allergy label. Pediatrics 2018; 141 (05) e20173466
    CrossrefPubMedGoogle Scholar
  • 48 Blumenthal KG, Oreskovic NM, Fu X. et al. High-cost, high-need patients: the impact of reported penicillin allergy. Am J Manag Care 2020; 26 (04) 154-161
    CrossrefPubMedGoogle Scholar